TELA Bio Awarded Biosynthetic Mesh Products Agreement with a

14.02.2023 - MALVERN, Pa., Feb. 14, 2023 (GLOBE NEWSWIRE) - TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative technologies that optimize clinical outcomes by prioritizing the preservation and ...

Related Keywords

Antony Koblish , Greg Chodaczek , Alyson Kuritz , Exchange Commission , Bio Inc , Nasdaq , Ovitex Reinforced Tissue Matrix , Tex Reinforced Tissue Matrix , Private Securities Litigation Reform Act , Annual Report , Quarterly Reports ,